Unknown

Dataset Information

0

Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.


ABSTRACT: Inactivating mutations in glucokinase (GCK) cause mild fasting hyperglycemia. Identification of a GCK mutation has implications for treatment and prognosis; therefore, it is important to identify these individuals. A significant number of patients have a phenotype suggesting a defect in glucokinase but no abnormality of GCK. We hypothesized that the GCK beta-cell promoter region, which currently is not routinely screened, could contain pathogenic mutations; therefore, we sequenced this region in 60 such probands.The beta-cell GCK promoter was sequenced in patient DNA. The effect of the identified novel mutation on GCK promoter activity was assessed using a luciferase reporter gene expression system. Electrophoretic mobility shift assays (EMSAs) were used to determine the impact of the mutation on Sp1 binding.A novel -71G>C mutation was identified in a nonconserved region of the human promoter sequence in six apparently unrelated probands. Family testing established cosegregation with fasting hyperglycemia (> or = 5.5 mmol/l) in 39 affected individuals. Haplotype analysis in the U.K. family and four of the Slovakian families demonstrated that the mutation had arisen independently. The mutation maps to a potential transcriptional activator binding site for Sp1. Reporter assays demonstrated that the mutation reduces promoter activity by up to fourfold. EMSAs demonstrated a dramatic reduction in Sp1 binding to the promoter sequence corresponding to the mutant allele.A novel beta-cell GCK promoter mutation was identified that significantly reduces gene expression in vitro through loss of regulation by Sp1. To ensure correct diagnosis of potential GCK-MODY (maturity-onset diabetes of the young) cases, analysis of the beta-cell GCK promoter should be included.

SUBMITTER: Gasperikova D 

PROVIDER: S-EPMC2712784 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.

Gasperíková Daniela D   Tribble Nicolas D ND   Staník Juraj J   Hucková Miroslava M   Misovicová Nadezda N   van de Bunt Martijn M   Valentínová Lucia L   Barrow Beryl A BA   Barák L'ubomir L   Dobránsky Radoslav R   Bereczková Eva E   Michálek Jozef J   Wicks Kate K   Colclough Kevin K   Knight Julian C JC   Ellard Sian S   Klimes Iwar I   Gloyn Anna L AL  

Diabetes 20090501 8


<h4>Objective</h4>Inactivating mutations in glucokinase (GCK) cause mild fasting hyperglycemia. Identification of a GCK mutation has implications for treatment and prognosis; therefore, it is important to identify these individuals. A significant number of patients have a phenotype suggesting a defect in glucokinase but no abnormality of GCK. We hypothesized that the GCK beta-cell promoter region, which currently is not routinely screened, could contain pathogenic mutations; therefore, we sequen  ...[more]

Similar Datasets

| S-EPMC3786513 | biostudies-literature
| S-EPMC4032240 | biostudies-literature
| S-EPMC3385652 | biostudies-literature
| S-EPMC5618154 | biostudies-literature
| S-EPMC6813687 | biostudies-literature
| S-EPMC6329793 | biostudies-literature
| S-EPMC2646078 | biostudies-literature
2016-10-15 | GSE86949 | GEO
| S-EPMC3590488 | biostudies-literature
| S-EPMC3099725 | biostudies-literature